147 related articles for article (PubMed ID: 35472507)
1. Serum Zinc Levels in Chronic Kidney Disease Patients, Hemodialysis Patients, and Healthy Controls: Systematic Review and Meta-Analysis.
Elgenidy A; Amin MA; Awad AK; Husain-Syed F; Aly MG
J Ren Nutr; 2023 Jan; 33(1):103-115. PubMed ID: 35472507
[TBL] [Abstract][Full Text] [Related]
2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
3. Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis.
Mah JY; Choy SW; Roberts MA; Desai AM; Corken M; Gwini SM; McMahon LP
Cochrane Database Syst Rev; 2020 May; 5(5):CD012616. PubMed ID: 32390133
[TBL] [Abstract][Full Text] [Related]
4. Haemodialysis alters the serum metal contents in chronic kidney failure patients at hyderabad and adjoining areas.
Shaikh M; Channa NA; Wahryah AM; Mugheri MH; Samejo S; Noorani L
Biometals; 2023 Feb; 36(1):129-135. PubMed ID: 36417038
[TBL] [Abstract][Full Text] [Related]
5. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
[TBL] [Abstract][Full Text] [Related]
6. Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta-analysis.
Liu J; Zhang A; Hayden JC; Bhagavathula AS; Alshehhi F; Rinaldi G; Kontogiannis V; Rahmani J
Pharmacol Res; 2020 May; 155():104747. PubMed ID: 32171893
[TBL] [Abstract][Full Text] [Related]
7. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
[TBL] [Abstract][Full Text] [Related]
8. Effect of Ascorbic Acid on Mineral and Bone Disorders in Hemodialysis Patients: a Systematic Review and Meta-Analysis.
Ke G; Huang J; Zhu Y; Yang J; Zhang Y; Chen L; Hu J; Tao S; Hu Y; Yang D; Liu S
Kidney Blood Press Res; 2018; 43(5):1459-1471. PubMed ID: 30248670
[TBL] [Abstract][Full Text] [Related]
9. Chemerin levels in chronic kidney disease: A systematic review and meta-analysis.
Behnoush AH; Shobeiri P; Bahiraie P; Amirkhani N; Khalaji A; Peiman S
Front Endocrinol (Lausanne); 2023; 14():1120774. PubMed ID: 36761204
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone antagonists for people with chronic kidney disease requiring dialysis.
Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S
BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030
[TBL] [Abstract][Full Text] [Related]
14. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Patel L; Bernard LM; Elder GJ
Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels.
Abujrad H; Mayne J; Ruzicka M; Cousins M; Raymond A; Cheesman J; Taljaard M; Sorisky A; Burns K; Ooi TC
Atherosclerosis; 2014 Mar; 233(1):123-9. PubMed ID: 24529132
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Hemodialysis on T Regulatory Cells: A Meta-Analysis and Systematic Review.
Caprara C; Kinsey GR; Corradi V; Xin W; Ma JZ; Scalzotto E; Martino FK; Okusa MD; Nalesso F; Ferrari F; Rosner M; Ronco C
Blood Purif; 2016; 42(4):307-313. PubMed ID: 27694753
[TBL] [Abstract][Full Text] [Related]
17. Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.
Htay H; Johnson DW; Craig JC; Teixeira-Pinto A; Hawley CM; Cho Y
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012899. PubMed ID: 33501650
[TBL] [Abstract][Full Text] [Related]
18. Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms.
Thomson BK; Nolin TD; Velenosi TJ; Feere DA; Knauer MJ; Asher LJ; House AA; Urquhart BL
Am J Kidney Dis; 2015 Apr; 65(4):574-82. PubMed ID: 25453994
[TBL] [Abstract][Full Text] [Related]
19. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.
Ozturk S; Turgutalp K; Arici M; Odabas AR; Altiparmak MR; Aydin Z; Cebeci E; Basturk T; Soypacaci Z; Sahin G; Elif Ozler T; Kara E; Dheir H; Eren N; Suleymanlar G; Islam M; Ogutmen MB; Sengul E; Ayar Y; Dolarslan ME; Bakirdogen S; Safak S; Gungor O; Sahin I; Mentese IB; Merhametsiz O; Oguz EG; Genek DG; Alpay N; Aktas N; Duranay M; Alagoz S; Colak H; Adibelli Z; Pembegul I; Hur E; Azak A; Taymez DG; Tatar E; Kazancioglu R; Oruc A; Yuksel E; Onan E; Turkmen K; Hasbal NB; Gurel A; Yelken B; Sahutoglu T; Gok M; Seyahi N; Sevinc M; Ozkurt S; Sipahi S; Bek SG; Bora F; Demirelli B; Oto OA; Altunoren O; Tuglular SZ; Demir ME; Ayli MD; Huddam B; Tanrisev M; Bozaci I; Gursu M; Bakar B; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Ates K
Nephrol Dial Transplant; 2020 Dec; 35(12):2083-2095. PubMed ID: 33275763
[TBL] [Abstract][Full Text] [Related]
20. Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients.
Al-Mansouri A; Al-Ali FS; Hamad AI; Mohamed Ibrahim MI; Kheir N; Ibrahim RA; AlBakri M; Awaisu A
Res Social Adm Pharm; 2021 Nov; 17(11):1937-1944. PubMed ID: 33612446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
